We are live on ! Find out more
IMCC

IM Cannabis

5 hedge funds and large institutions have $316K invested in IM Cannabis in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.38% less ownership

Funds ownership: 6.38% → 6% (-0.38%)

44% less funds holding

Funds holding: 9 → 5 (-4)

73% less capital inflows, than outflows

Capital inflows: $8.8K | Capital outflows: $32.8K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMCC Hedge Fund Activity: Q3 2024 in Review

5 of the 6,986 institutional investors tracked by Wall St. Rank reported a position in IM Cannabis (IMCC) for Q3 2024, worth a combined $316K — down 20% from $395K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMCC and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $8.04K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23K sold.

  • 5 institutional investors held IM Cannabis (IMCC) as of Q3 2024, down from 9 in Q2 2024.
  • Funds reported $316K of IM Cannabis stock for Q3 2024, down 20% quarter-over-quarter.
  • 0 funds opened new IM Cannabis positions in Q3 2024 and 4 closed out, a net change of -4 holders.
  • The largest IM Cannabis buyer in Q3 2024 was Citadel Advisors, an estimated $8.04K added.
  • The largest IM Cannabis seller in Q3 2024 was Renaissance Technologies, an estimated $23K sold.

Based on aggregated 13F filings for Q3 2024.